Patents by Inventor J. Allan Campbell

J. Allan Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4557867
    Abstract: Known reactions are arranged in a novel manner to produce 11.beta.-difluoromethyl and (E)- and (Z)-11-fluoromethylene 19-norandrostenediones and 19-nor-13.beta.-ethylandrostenediones which are useful as contraceptive agents.
    Type: Grant
    Filed: August 8, 1984
    Date of Patent: December 10, 1985
    Assignee: The Upjohn Company
    Inventor: J. Allan Campbell
  • Patent number: 4416822
    Abstract: 17.beta.-Difluoromethyl steroids are disclosed which have progestational, antiprogestational activity and which are useful as and male and female contraceptive agents.
    Type: Grant
    Filed: July 9, 1982
    Date of Patent: November 22, 1983
    Assignee: The Upjohn Company
    Inventor: J. Allan Campbell
  • Patent number: 4297350
    Abstract: The steroids of the present invention have been found to be useful as male contraceptives when administered orally. Upon cessation of administration of the male contraceptive steroids of the present invention the male promptly regains normal fertility.
    Type: Grant
    Filed: October 10, 1978
    Date of Patent: October 27, 1981
    Assignee: The Upjohn Company
    Inventors: John C. Babcock, J. Allan Campbell, Thomas J. Lobl
  • Patent number: 4013688
    Abstract: Novel steroid derivatives containing a tyrosine ester amide group linked to an 11-hydroxysteroid alkylene dicarboxylic hemi-ester are described, suitable for iodination with radioactive iodine, useful in radioimmunoassay.
    Type: Grant
    Filed: December 20, 1972
    Date of Patent: March 22, 1977
    Assignee: The Upjohn Company
    Inventors: John C. Babcock, J. Allan Campbell
  • Patent number: 4004003
    Abstract: A process for the prevention or treatment of osteoporosis induced as a side effect of the administration of glucocorticoid steroids by the administration of a compound of the formula: ##STR1## WHEREIN R.sub.1 and R.sub. 2 are the same or different radicals selected from the group consisting of hydrogen, alkyl of less than 9 carbon atoms, and phenyl; R.sub.3 and R.sub. 5 are selected from the group consisting of hydrogen and lower acyl; n is an integer, selected from the group consisting of 2, 3, and 4; or a hydrate thereof in association with a pharmaceutical carrier to a human or animal being treated or having been treated with a gluco-corticoid hormone.
    Type: Grant
    Filed: October 6, 1975
    Date of Patent: January 18, 1977
    Assignee: The Upjohn Company
    Inventors: John C. Babcock, J. Allan Campbell
  • Patent number: 3980638
    Abstract: Novel testosterone 17-ether 2,3-isoxazole and 2-cyano derivatives are disclosed as useful steroid enzyme inhibitors and for other pharmaceutical purposes.
    Type: Grant
    Filed: September 20, 1974
    Date of Patent: September 14, 1976
    Assignee: The Upjohn Company
    Inventors: John C. Babcock, J. Allan Campbell